pubmed-article:18547343 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18547343 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:18547343 | lifeskim:mentions | umls-concept:C0032460 | lld:lifeskim |
pubmed-article:18547343 | lifeskim:mentions | umls-concept:C0025598 | lld:lifeskim |
pubmed-article:18547343 | lifeskim:mentions | umls-concept:C0021655 | lld:lifeskim |
pubmed-article:18547343 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:18547343 | lifeskim:mentions | umls-concept:C0076275 | lld:lifeskim |
pubmed-article:18547343 | lifeskim:mentions | umls-concept:C0071097 | lld:lifeskim |
pubmed-article:18547343 | lifeskim:mentions | umls-concept:C0444504 | lld:lifeskim |
pubmed-article:18547343 | lifeskim:mentions | umls-concept:C0205460 | lld:lifeskim |
pubmed-article:18547343 | lifeskim:mentions | umls-concept:C2827666 | lld:lifeskim |
pubmed-article:18547343 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:18547343 | pubmed:dateCreated | 2009-2-9 | lld:pubmed |
pubmed-article:18547343 | pubmed:abstractText | Mean insulin resistance (IR) is greater and it is also more variable in overweight women with polycystic ovarian syndrome (PCOS) compared to weight matched controls. Whilst treatment will reduce the mean IR, it is not known if the IR variability is also reduced. | lld:pubmed |
pubmed-article:18547343 | pubmed:language | eng | lld:pubmed |
pubmed-article:18547343 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18547343 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18547343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18547343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18547343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18547343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18547343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18547343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18547343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18547343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18547343 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18547343 | pubmed:month | Feb | lld:pubmed |
pubmed-article:18547343 | pubmed:issn | 1365-2265 | lld:pubmed |
pubmed-article:18547343 | pubmed:author | pubmed-author:HANT HTH | lld:pubmed |
pubmed-article:18547343 | pubmed:author | pubmed-author:KilpatrickE... | lld:pubmed |
pubmed-article:18547343 | pubmed:author | pubmed-author:CoadyA MAM | lld:pubmed |
pubmed-article:18547343 | pubmed:author | pubmed-author:AtkinS LSL | lld:pubmed |
pubmed-article:18547343 | pubmed:author | pubmed-author:KeevilB GBG | lld:pubmed |
pubmed-article:18547343 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18547343 | pubmed:volume | 70 | lld:pubmed |
pubmed-article:18547343 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18547343 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18547343 | pubmed:pagination | 233-7 | lld:pubmed |
pubmed-article:18547343 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:18547343 | pubmed:meshHeading | pubmed-meshheading:18547343... | lld:pubmed |
pubmed-article:18547343 | pubmed:meshHeading | pubmed-meshheading:18547343... | lld:pubmed |
pubmed-article:18547343 | pubmed:meshHeading | pubmed-meshheading:18547343... | lld:pubmed |
pubmed-article:18547343 | pubmed:meshHeading | pubmed-meshheading:18547343... | lld:pubmed |
pubmed-article:18547343 | pubmed:meshHeading | pubmed-meshheading:18547343... | lld:pubmed |
pubmed-article:18547343 | pubmed:meshHeading | pubmed-meshheading:18547343... | lld:pubmed |
pubmed-article:18547343 | pubmed:meshHeading | pubmed-meshheading:18547343... | lld:pubmed |
pubmed-article:18547343 | pubmed:meshHeading | pubmed-meshheading:18547343... | lld:pubmed |
pubmed-article:18547343 | pubmed:meshHeading | pubmed-meshheading:18547343... | lld:pubmed |
pubmed-article:18547343 | pubmed:meshHeading | pubmed-meshheading:18547343... | lld:pubmed |
pubmed-article:18547343 | pubmed:meshHeading | pubmed-meshheading:18547343... | lld:pubmed |
pubmed-article:18547343 | pubmed:meshHeading | pubmed-meshheading:18547343... | lld:pubmed |
pubmed-article:18547343 | pubmed:meshHeading | pubmed-meshheading:18547343... | lld:pubmed |
pubmed-article:18547343 | pubmed:meshHeading | pubmed-meshheading:18547343... | lld:pubmed |
pubmed-article:18547343 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:18547343 | pubmed:articleTitle | Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome. | lld:pubmed |
pubmed-article:18547343 | pubmed:affiliation | Department of Medicine, University of Hull, Hull, UK. l.cho@hull.ac.uk | lld:pubmed |
pubmed-article:18547343 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18547343 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18547343 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18547343 | lld:pubmed |